CytoDyn Inc.
CYDY
$0.25
-$0.01-2.40%
OTC PK
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -374.14% | -128.81% | 64.52% | 60.08% | 50.14% |
| Total Depreciation and Amortization | 25.00% | -20.00% | 0.00% | -28.57% | -50.00% |
| Total Amortization of Deferred Charges | -- | -- | -52.80% | -82.03% | -22.07% |
| Total Other Non-Cash Items | 5.69% | -91.74% | -93.81% | -99.81% | -89.93% |
| Change in Net Operating Assets | 2,822.53% | 118.07% | -106.91% | -114.58% | -74.36% |
| Cash from Operations | -21.31% | -145.04% | -243.21% | -112.25% | -43.33% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 80.00% | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -66.11% | -99.22% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -101.25% | -66.11% | -99.42% | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -21.31% | -117.02% | -351.09% | -479.91% | -94.05% |